# The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients

> **NCT00114556** · PHASE4 · COMPLETED · sponsor: **Royal Prince Alfred Hospital, Sydney, Australia** · enrollment: 100 (—)

## Conditions studied

- Osteoporosis
- Liver Transplantation
- Fractures

## Interventions

- **DRUG:** zoledronic acid

## Key facts

- **NCT ID:** NCT00114556
- **Lead sponsor:** Royal Prince Alfred Hospital, Sydney, Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-02
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** 100 (—)
- **Last updated:** 2006-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00114556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00114556, "The Effect of Zoledronic Acid on Bone Density in Liver Transplant Patients". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00114556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*